EMA Authorised: Eurartesim (piperaquine tetraphosphate;artenimol) — Alfasigma S.p.A.

View source ↗

Summary

The EMA has authorised Eurartesim for malaria treatment in the European Union. The product combines piperaquine tetraphosphate and artenimol, with Alfasigma S.p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Eurartesim (piperaquine tetraphosphate; artenimol)

Snippet

Status: Authorised. Therapeutic area: Malaria. MAH: Alfasigma S.p.A.. Decision date: 03/09/2025